MJNA-LOGOMedical Marijuana, Inc. is the first publicly held company vested in the industrial hemp and legal cannabis industries. It is a company made up of a diversified portfolio of products, services, business, and technology focused completely on the production of high concentrate hemp oil products that are rich in cannabinoid. Medical Marijuana, Inc. trades in the OTC market under the symbol MJNA.

Medical Marijuana, Inc. aims to be the premier innovator in the hemp and cannabis industry, leveraging its team of professionals into sourcing, evaluating, and purchasing value-added products and companies. It strives to do so while simultaneously allowing them to keep their entrepreneurial spirit and integrity. The company also commits to create awareness within the industry, and develop environmentally friendly and economically stable businesses while increasing the value of their shareholders.

Medical Marijuana, Inc.’s range of products stem anywhere from proprietary and patented cannabinoid-based products to seed and stalk or unique high value extracts that are purposely formulated and manufactured for the cosmetics, nutraceutical, pharmaceutical, and food industries.

The company offers a varied and extensive selection of services, such as medical clinic management, development of existing industry business and product leaders, development of medical grade compounds, and development of cannabinoid-based health and wellness products. At present, Medical Marijuana, Inc. provides more than 80 proprietary and patent pending cannabinoid delivery methods, which are deemed more medically and socially acceptable compared to the usual industry methods.

Other services offered by Medical Marijuana, Inc. include licensing of its proprietary testing, labeling, genetics, packaging, production, tracking, and standardization of methods for the medicinal herb industry.

Medical Marijuana, Inc.’s portfolio companies include Canipa Holdings, Red Dice Holdings, Wellness Managed Services, HempMeds PX, KannaLife Sciences, Phytosphere, and CanChew Gum. Whether wholly owned or partially owned, all these businesses are integral part of Medical Marijuana, Inc. Featured products of these companies are Cibdex, Cibaderm, Dixie Botanicals, and Real Scientific Hemp Oil.


Yahoo! Finance: MJNA News

Latest Financial News for MJNA

Medical Marijuana, Inc. Opens New Production & Warehousing Facility to Expedite International Expansion Efforts

Medical Marijuana, Inc. (MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today the expansion of its operations with a new production and warehouse facility. The facility has been designed to help the Company increase warehousing, fulfillment and production activities related to the Company’s CBD hemp oil products.

Medical Marijuana, Inc. Subsidiary Kannaway® Grows International Leadership Team With Janne Heimonen as Managing Director of European Division

SAN DIEGO, July 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that that its subsidiary Kannaway® has appointed Janne Heimonen as Managing Director of its burgeoning European Division. Kannaway® currently ships its products to many countries within the EU. The company is working to expand access to CBD and hemp throughout Europe and has grown to a nearly $40 million revenue run rate since its official launch in 2018.

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Updated Branding Strategy and Website to Expand Consumer Reach

SAN DIEGO, July 11, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a completely redesigned website and the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products. Through its newly designed consumer-driven website, the Company hopes that consumers will find it easier to navigate for access to the products and CBD education that fits their unique lifestyles.

Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Announce June 2019 as the Largest Sales Bookings Month in Company History

- Medical Marijuana, Inc. completed the first-ever high-level stability study on a cannabidiol (CBD) hemp oil product - Subsidiary Kannaway® began pre-marketing initiatives in Japan ahead of significant ...

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Industrial Hemp Association Membership

SAN DIEGO, July 2, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has become a member of the European Industrial Hemp Association (EIHA) and will participate in the organization's operational and legislative activities.